Articles related to DRY EYE DISEASE (DED)

Experts reviewing scleral lens care argue that underlying dry eye disease is a frequent but overlooked contributor to visual complaints among scleral lens wearers. The article emphasizes diagnostic evaluation and multimodal management strategies rather than new clinical trial evidence.

TFOS DEWS III proposes a driver-based approach to dry eye disease, emphasizing standardized diagnosis, disease subtyping, and layered treatment strategies matched to underlying mechanisms rather than rigid severity-based escalation.

Inconsistent cataract biometry measurements most commonly reflect ocular surface instability, subtle corneal pathology, or suboptimal measurement conditions rather than random error, and a systematic diagnostic approach before repeating scans can meaningfully improve refractive predictability.

Researchers at the National University of Singapore developed a spinach-derived nanotechnology delivering plant photosynthetic machinery into corneal cells via eye drops, demonstrating reversal of corneal damage to near-healthy levels within five days in preclinical models of dry eye disease.

Reproxalap is an investigational drug candidate for the treatment of dry eye disease.

Discover how Miebo, supported by phase 3 clinical trials, offers a unique approach to dry eye disease by specifically targeting tear evaporation.